US NYSE stock alert
CLOSING UPDATE: Merck and Co. decreased further 0.4% - underperforming 93% of stocks 26 July 2017 17:53 EDT
NEWS BITES - NORTH AMERICA
This is an end of day Alert, produced after today's NYSE market close. It concludes the BSS News Bites intra-day Alert series (summaries below).
Merck and Co., NYSE's 3rd largest pharmaceuticals company by market capitalisation, has decreased 56.0c (or 0.9%) today to trade at $US61.80 and has underperformed 93% of the market in the past month. Compared with the S&P 500 Index which rose 0.7 points (or 0.03%) in the day, this represented a relative price change of -0.9%.
Technical indicators complementing today's significant downtrend:
+ The negative 0.52 MACD (Moving Average Convergence Divergence) indicator suggests a bearish signal.
+ The price decreased 1.3% in the last week and tumbled 6.2% in the last month.
Fundamental measures by comparison with the sector average [in brackets] indicate:
+ Price/Earnings of 43.8 [29.8]
+ Return on Equity 9.9% [12.7%]
+ Return on Assets 4.1% [5.1%]
+ Return on Capital Employed 6% [8.3%]
Other Bearish Signals include:
+ As per the Du Pont analysis, Return on Equity of 9.9% is lower than sector average of 12.7%.
Merck and Co. today is at a discount of 7.5% to the 12-month high of $US66.80 on 01 Mar, 2017. It is at a premium of 8.1% to the 12-month low of $US57.18 on 03 Aug, 2016.
Tobin's Q Ratio is 1.8. Compared with the rest of the market the stock is undervalued.
Net profit margin has averaged 16.5% in the last 3 years. This is considered superior and suggests a high margin of safety.
Afternoon Alert: Merck and Co. decreases 0.5% - underperforming 88% of stocks
26 July 2017 13:10 EDT
Merck & Co., Inc. (NYSE:MRK) has decreased 33.0c (or 0.5%) today to trade at $US62.03 and has underperformed 88% of the market in the past month.
CLOSING UPDATE: Merck and Co. decreased 0.3%
25 July 2017 17:54 EDT
Merck and Co., NYSE's 3rd largest pharmaceuticals company by market capitalisation, traded on volume of 0.5 times average today while the price decreased 21.0c (or 0.3%) to trade at $US62.36. Compared with the S&P 500 Index which rose 7.2 points (or 0.3%) in the day, this represented a relative price change of -0.6%.
Morning Alert: Merck and Co. inches higher, resistance at 12-day EMA
25 July 2017 11:24 EDT
Merck & Co., Inc. (NYSE:MRK) has increased 0.1% but fell short of the 12-day Exponential Moving Average [EMA] of $US62.88.
Merck & Co., Inc. (N:MRK)